Pulsewatch: Smartwatch Monitoring for Atrial Fibrillation After Stroke
| Status: | Not yet recruiting |
|---|---|
| Conditions: | Atrial Fibrillation, Neurology |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Neurology |
| Healthy: | No |
| Age Range: | 50 - 100 |
| Updated: | 3/23/2019 |
| Start Date: | May 2019 |
| End Date: | December 31, 2021 |
| Contact: | Timothy Fitzgibbons, MD, Phd |
| Email: | timothy.fitzgibbons@umassmed.edu |
| Phone: | 508-856-6858 |
Smartwatch Monitoring for Atrial Fibrillation After Stroke
The goal of this research study is to develop a smartphone application capable of monitoring
paroxysmal atrial fibrillation (pAF) in people who have survived a stroke or transient
ischemic attack (TIA) and are age 50 and older. The study team plans to develop a highly
effective and easy to use cardiovascular surveillance system to monitor patients for pAF on a
nearly continuous basis. People involved in the development of this system include patients,
their caregivers, health care providers, and computer programmers.
paroxysmal atrial fibrillation (pAF) in people who have survived a stroke or transient
ischemic attack (TIA) and are age 50 and older. The study team plans to develop a highly
effective and easy to use cardiovascular surveillance system to monitor patients for pAF on a
nearly continuous basis. People involved in the development of this system include patients,
their caregivers, health care providers, and computer programmers.
Inclusion Criteria:
- History of Transient Ischemic Attack (TIA) or stroke, presenting at the UMass Memorial
Medical Center (UMMMC) inpatient service or ambulatory clinic (neurology clinics and
cardiovascular clinics included)
- Age: greater to or equal to 50 years of age
- Able to sign informed consent
- Willing to participant in a focus groups and/or Hack-a-thon for Aim 1 participants
only
- Willing and capable of using Pulsewatch (smartwatch and smartphone app) daily for up
to 44-days and returning to UMMMC for up to two study visits for Aims 2 and 3
participants only
Exclusion Criteria:
- Serious physical illness (e.g., unable to interact with a smart device, or communicate
verbally or via written text) that would interfere with study participation
- Lacking capacity to sign informed consent
- Unable to read and write in English
- Plans to move from the area during the study period
- Unwilling to complete all study procedures
- Major contraindication to anti-coagulation treatment (i.e., major hemorrhagic stroke)
- Individuals who are not yet adults
- Pregnant women
- Prisoners
We found this trial at
1
site
Click here to add this to my saved trials
